Would you choose CAR-T or BMT for an AYA patient with Ph negative ALL with induction failure, who is now MRD negative after blinatumomab?
Patient received adult ALL protocol AYA regimen CALGB 10403 with two weeks extension. All Ph-like aberrations are negative.
Community PollStarted
Would you choose CAR-T or BMT for this patient
8 physicians have voted
Join Mednetto vote and see how they answered.